Colchicine and dialysis patients; a feasibility study
Haemodialysis
Colchicine 0.5 mg once daily orally will be given for 3 months and 2 weeks to all enrolled patients
1. Anyone who is undergoing haemodialysis 2. Aged 18 years or over 3. Able to give informed consent
1. Already taking colchicine for a clinical indication. 2. Taking a drug known to increase colchicine levels. 3. Has a previously documented intolerance of or allergy to colchicine 4. Has a history of chronic liver disease, or abnormal liver function (i.e. ALT > 1.5 x upper limit of normal). Patients with a history of hepatitis are eligible provided these limits are not exceeded.